Sponsor Pipeline

Suven Life Sciences Limited Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
2
Phase 3
2
Disease Areas
Active Trials by Phase
Phase 3
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05397639 Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type Agitation Recruiting
NCT07540364 A Phase 3 Study to Evaluate the Efficacy and Safety of Samelisant in Patients With… Narcolepsy Not Yet Recruiting
Disease Areas
Alzheimer's Disease (1) Dementia (1)
Get alerts when Suven Life Sciences Limited's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free